Professor Oliver Hanemann (IMAGE)

University of Plymouth

Professor Oliver Hanemann

Caption

Professor Oliver Hanemann is leading the RETREAT trial, which will explore whether anti-retroviral medications could help people with Neurofibromatosis 2 (NF2)

Credit

University of Plymouth

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.